NEW YORK – September 09, 2026 -- Consumer365 has named telehealth provider Happy Head its 2026 pick for personalized minoxidil formulas for women, citing the company's dermatologist-prescribed, compounded hair-loss treatments that vary by age, medical history, and delivery method.
Consumer365 reviewed more than 200 possible formulations
The report examined Happy Head's topical preparations containing up to 8% minoxidil and oral regimens that may combine minoxidil with other prescription ingredients. Patients complete a remote health assessment, which a board-certified dermatologist reviews before issuing a prescription when medically appropriate. Each compounded formula is made fresh per order and shipped to the patient's home, with dermatology support available for adjustments based on tolerance.
Product options are grouped by age, not automatic eligibility
For women 50 and older, Happy Head offers TopicalRx SuperSolution ProBlend, an 8% minoxidil scalp solution with additional active ingredients; a combined topical-and-capsule regimen pairing minoxidil with dutasteride and vitamin D3; and an oral SuperCapsule containing dutasteride, minoxidil, and vitamin D3. For women under 50, options include a topical solution combining minoxidil with retinoic acid, and spironolactone, an oral option that is not a form of minoxidil. Happy Head states that finasteride and dutasteride are not recommended for women who are pregnant, breastfeeding, or planning pregnancy.
Topical and oral minoxidil carry different risk profiles
Topical minoxidil is applied to the scalp, while oral minoxidil is swallowed and produces systemic effects. Because delivery route, dosage, and paired ingredients can affect side effects and suitability, Happy Head requires a licensed clinician to evaluate each patient before treatment begins.
Care is delivered entirely online, with no office visit required
Patients complete an online assessment reviewed by a board-certified dermatologist; if approved, a customized monthly treatment is compounded and shipped. Happy Head says many patients may see visible regrowth within three to six months of consistent use, though individual timelines and outcomes vary and no result is guaranteed.
Compounded medications are not FDA-approved
Happy Head notes that some ingredients or uses may be prescribed off-label, and that treatment suitability must be determined by a licensed healthcare provider rather than by age category or editorial recognition. Happy Head was co-founded by dermatologist Dr. Ben Behnam and hair transplant surgeon Dr. Sean Behnam, drawing on more than 15 years of combined clinical experience in hair restoration.